Oscar Health, Inc.OSCRNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +67.11% | +42.16% | +29.04% | +23.21% | +17.25% |
| Gross Profit Growth | -77.14% | -63.29% | -85.99% | -83.51% | -43.43% |
| EBITDA Growth | +0.00% | +56.58% | -396.10% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +66.48% | -478.16% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +55.20% | -506.29% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +42.86% | -470.83% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +48.39% | -566.67% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +5.86% | +8.57% | +6.18% | +6.65% | +17.83% |
| Weighted Average Shares Diluted Growth | +17.07% | +4.13% | -11.09% | +6.65% | +6.54% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +16.83% | +38.49% | +2.40% | +0.00% | +93.73% |
| Free Cash Flow Growth | +16.93% | +38.37% | +2.08% | +0.00% | +94.95% |
| Receivables Growth | -36.10% | +17.84% | +4.77% | +48.19% | +40.13% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +34.40% | +32.25% | +27.53% | +28.17% | +30.68% |
| Book Value per Share Growth | +19.10% | +18.97% | -4.15% | -17.42% | -18.14% |
| Debt Growth | +0.26% | +0.26% | +0.26% | +129.25% | +43.58% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | -100.00% | -100.00% | -100.00% | +0.00% |